Olympus and EndoRobotics Forge Distribution Pact
Olympus has partnered with EndoRobotics to exclusively distribute the South Korea-based company’s endoscopic robotic devices for gastroenterology globally, starting in the U.S. The agreement was announced on May 4, 2026, and follows Olympus’ previous collaboration with Revival Healthcare Capital to co-launch Swan EndoSurgical, a startup developing a robotic gastrointestinal platform.
Details
The partnership will see Olympus distribute EndoRobotics’ Robopera system console and accessories, articulated grippers, scope-mounted traction device, and EndoCubot ESD training simulator and accessories. These technologies are designed to enhance precision in complex procedures such as endoscopic submucosal dissection (ESD) for removing tumors or lesions in the gastrointestinal tract.
Company Background
Olympus, founded in 1919 and based in Tokyo, is a leading manufacturer in the medical and scientific equipment industry. The company is known for its innovative endoscopic devices and has a strong presence in the field of gastrointestinal treatment technologies.
Market Context
This collaboration is significant as it combines Olympus’ commercial infrastructure with EndoRobotics’ development capabilities, aiming to broaden the adoption of advanced endoscopic procedures. The agreement is expected to improve patient outcomes by minimizing complications and shortening recovery times in treating early-stage GI cancers and precancerous lesions.
If you are exploring product design and medical device engineering, BangDesign has relevant experience.
Source: MedTech Dive